When did DESIGN THERAPEUTICS INC (DSGN) report earnings last quarter?
DESIGN THERAPEUTICS INC (DSGN) last reported earnings on 3/9/2026.
NASDAQ:DSGN • US25056L1035
Past quarterly earnings results for DESIGN THERAPEUTICS INC (DSGN), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.27 | -0.36 | 25.22% | -12.50% | - | - | ||
| Q3 2025 | -0.30 | -0.35 | 14.33% | -30.43% | - | - | ||
| Q2 2025 | -0.34 | -0.34 | -1.01% | -61.90% | - | - | ||
| Q1 2025 | -0.31 | -0.29 | -8.54% | -55.00% | - | - | ||
| Q4 2024 | -0.24 | -0.27 | 11.77% | -14.29% | - | - | ||
| Q3 2024 | -0.23 | -0.25 | 7.33% | 17.86% | - | - | ||
| Q2 2024 | -0.21 | -0.24 | 11.76% | 41.67% | - | - | ||
| Q1 2024 | -0.20 | -0.27 | 25.54% | 42.86% | - | - | ||
| Q4 2023 | -0.21 | -0.32 | 33.53% | 32.26% | - | - | ||
| Q3 2023 | -0.28 | -0.42 | 32.80% | 12.50% | - | - | ||
| Q2 2023 | -0.36 | -0.41 | 11.21% | -33.33% | - | - | ||
| Q1 2023 | -0.35 | -0.37 | 4.49% | -45.83% | - | - | ||
| Q4 2022 | -0.31 | -0.35 | 11.65% | -55.00% | - | - | ||
| Q3 2022 | -0.32 | -0.29 | -8.93% | -52.38% | - | - | ||
| Q2 2022 | -0.27 | -0.26 | -5.88% | -92.86% | - | - | ||
| Q1 2022 | -0.24 | -0.22 | -6.95% | 22.58% | - | - | ||
| Q4 2021 | -0.20 | -0.23 | 13.50% | - | - | - | ||
| Q3 2021 | -0.21 | -0.14 | -47.06% | - | - | - | ||
| Q2 2021 | -0.14 | -0.19 | 25.13% | - | - | -100.00% | ||
| Q1 2021 | -0.31 | -0.07 | -314.46% | - | - | -100.00% | ||
| Q2 2020 | - | - | 30K | - | - | |||
| Q1 2020 | - | - | 140K | - | - |
Notes
DESIGN THERAPEUTICS INC (DSGN) last reported earnings on 3/9/2026.
DESIGN THERAPEUTICS INC (DSGN) beat EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, DESIGN THERAPEUTICS INC (DSGN) has beaten EPS estimates in 2 out of 4 releases.